Jim Anthony

Jim Anthony is President and Global Head, Parexel Biotech. In this role he leads the fully dedicated, cross-departmental division responsible for serving Parexel’s small, emerging and mid-sized Biotech and Biopharma customers. Jim successfully leverages critical insights across all aspects of customer engagement, project execution and delivery to drive industry-leading growth in this critical segment.

Prior to leading Parexel Biotech, Jim was an Enterprise Account Group Lead, a leadership role that included direct management of two of the company’s largest large pharma customers. He delivered success and growth on these customer relationships,  with one partnership being renewed for a second, five-year term and the second partnership being built and launched from the ground up. He joined Parexel in 2010 as Vice President, North America Business Development and was promoted to Corporate Vice President in 2013. 

Jim has more than 25 years of pharmaceutical development and CRO experience, including positions with Kendle International (now Syneos Health) and SCIREX Corporation (now Premier Research). In 2022, he was recognized as a PharmaVoice 100 award recipient, a prestigious accolade that recognizes the 100 most-inspiring individuals in the life sciences sector.

Jim holds a Bachelor of Arts degree from Columbia University (NY) and a Master of Business Administration degree from the University of Cincinnati.